Anne‐Catherine Fitchette

Biochemistry, Genetics and Molecular Biology · Life Sciences

12h-index1.5kcitations30works1.22yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Transgenic Plants and Applications(15), Allergic Rhinitis and Sensitization(12), Food Allergy and Anaphylaxis Research(10), Glycosylation and Glycoproteins Research(9), Carbohydrate Chemistry and Synthesis(5)

Publications30 total

Plant‐produced <scp>SARS</scp>‐<scp>CoV</scp>‐2 antibody engineered towards enhanced potency and in vivo efficacy
Plant Biotechnology Journal·2024· 2 citedOpen Access
Rapid induction of allergen‐blocking IgG in dogs vaccinated with plant‐based, Der f 2‐expressing bioparticles
Veterinary Dermatology·2024· 1 citedOpen Access
Vaccin de nouvelle génération pour traiter l’allergie au chat
Revue française d'allergologie·2024
First-in-class biologic to treat human allergy to cats
Journal of Allergy and Clinical Immunology·2024Open Access
Plant‐produced Der p 2‐bearing bioparticles activate Th1/Treg‐related activation patterns in dendritic cells irrespective of the allergic background
Clinical & Experimental Allergy·2024· 3 citedOpen Access
Fel d 1 surface expression on plant‐made <i>e</i>Bioparticles combines potent immune activation and hypoallergenicity
Allergy·2022· 11 citedOpen Access
Surface Expression of Major Allergens on Plant-Made eBioparticle Combines Hypo-Allergenicity with Potent Immune Activation
Journal of Allergy and Clinical Immunology·2022
Design, production and immunomodulatory potency of a novel allergen bioparticle
PLoS ONE·2020· 20 citedOpen Access
A new generation of high potency allergen bioparticles
World Allergy Organization Journal·2020Open Access
Nouveaux vaccins pour l’immunothérapie allergénique
Revue française d'allergologie·2020
Les avantages de la production d’allergènes moléculaires par les plantes
Revue française d'allergologie·2018
Preliminary indications regarding the safety and efficacy potential of allergen bearing bioparticles as an evolved form of immunotherapy
Journal of Allergy and Clinical Immunology·2018Open Access
P109 Harbinger of a new era in allergy treatment
Annals of Allergy Asthma & Immunology·2017
Production of high quality and natural-like recombinant allergens needed for high efficiency of allergy treatment
Clinical and Translational Allergy·2014Open Access
Glycoproteins are species‐specific markers and major IgE reactants in grass pollens
Plant Biotechnology Journal·2011· 16 citedOpen Access
Plant‐specific glycosylation patterns in the context of therapeutic protein production
Plant Biotechnology Journal·2010· 412 citedOpen Access
Mutations of an α1,6 Mannosyltransferase Inhibit Endoplasmic Reticulum–Associated Degradation of Defective Brassinosteroid Receptors in<i>Arabidopsis</i>   
The Plant Cell·2009· 78 citedOpen Access
N-glycan trimming by glucosidase II is essential for Arabidopsis development
Glycoconjugate Journal·2009· 2 citedOpen Access
N-Glycosylation of Plant Recombinant Pharmaceuticals
Methods in molecular biology·2009· 11 cited
Simple Tools for Complex N-Glycan Analysis
Springer protocols handbooks/Springer protocols·2009
page 1 of 2Next →

Frequent Co-authors

Loı̈c Faye(24), Véronique Gomord(22), Virginie Stordeur(13), Guy Tropper(11), Patrice Lerouge(7), Réjean Desgagnés(7), Ronald van Ree(7), L.‐P. Vézina(6), Muriel Bardor(5), Sébastien Viel(5), Caroline Martel(5), Louis‐Philippe Vézina(5), Bertrand Morel(5), Thomas Paccalet(4), Brian J. Ward(4), Lorenz Aglas(4), Maria Stigler(4), Lucie Mirande(4), Carole Plasson(3), Louis‐P. Vézina(3)